Changchun BCHT Biotechnology

Changchun BCHT Biotechnology is one of the...

• CSI 500.

Changchun BCHT Biotechnology is a company listed under the stock ticker 688276 (CN).

View the org chart displaying its 5 main executives

Most searched biographies at Changchun BCHT Biotechnology

• Da Qiang Feng, General Manager and Director
• Da Qiang Feng, Chairman of the Supervisory Board
• Ji Ma, Chairman

Create your alert
to follow the executive moves at Changchun BCHT Biotechnology.

Changchun BCHT Biotechnology has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Changchun BCHT Biotechnology

Social media about Changchun BCHT Biotechnology

• Changchun BCHT Biotechnology on Wikipedia, Google News & Yahoo Finance
• Changchun BCHT Biotechnology on LinkedIn, Twitter & YouTube

Contact by email its executives including Da Qiang Feng

Call Changchun BCHT Biotechnology at +86 431 ...

View the org chart

Register to receive your alert

Report an error